CC
TTPH

Clearline Capital’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Clearline Capital’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-13,396
Closed -$1.03M – 62
2016
Q3 		$1.03M Sell
13,396
-5,461
-29% -$437K 0.32% 41
2016
Q2 		$1.62M Sell
18,857
-2,022
-10% -$185K 0.32% 41
2016
Q1 		$1.93M Buy
+20,879
New +$2.09M 0.49% 33

Other funds holding TTPH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Clearline Capital's TTPH Position: Q4 2016 in Review

Clearline Capital sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q4 2016, closing a stake of 13,396 shares — an estimated $1.03M sold.

Clearline Capital first reported a position in TTPH in Q1 2016 and held it in 3 quarters. The position peaked at $1.93M in Q1 2016. 91 funds tracked by Wall St. Rank hold TTPH as of Q4 2016.

  • Clearline Capital reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
  • Clearline Capital sold 13,396 Tetraphase Pharmaceuticals, Inc. shares in Q4 2016, an estimated $1.03M.
  • Clearline Capital first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2016 and held it in 3 quarters.
  • Clearline Capital's Tetraphase Pharmaceuticals, Inc. position peaked at $1.93M in Q1 2016.
  • 91 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2016.

Based on Clearline Capital's 13F filing for Q4 2016, filed 14 Feb 2017.